Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and disposition.
about
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumorsTweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingMultivalent polymers for drug delivery and imaging: the challenges of conjugationStructure activity relationship of dendrimer microbicides with dual action antiviral activitySunflower Polymers for Folate-Mediated Drug Delivery.Effects of nanomaterial physicochemical properties on in vivo toxicity.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.Recent advances in targeted drug delivery approaches using dendritic polymers.Dendrimer-based nanocarriers: a versatile platform for drug delivery.Polymeric therapeutic delivery systems for the treatment of infectious diseases.Dendrimers in combination with natural products and analogues as anti-cancer agents.Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
P2860
Q21245468-DA07F980-E52F-4934-B7D6-7F46BF39B143Q26785347-11BA289F-7A4B-4FF7-8914-0F99A592CFC2Q27692689-1E52E25E-BA7E-4ED1-92D7-B0645152B1FEQ28749596-6DA52E88-E832-439A-B4F3-00C15BC2E1CBQ37276750-9CF8BC7E-740E-40C7-887C-C8808F75161AQ37345372-CC4DF4F6-7810-4120-881C-49003985F28DQ37823446-2D53BAD0-B8C8-4C94-8D16-C7928D254FFEQ37834336-DB838446-896B-47A1-B6C7-51ED6D7971F1Q37939967-B2AB6878-7DE8-4C0F-A3B8-3D6A0079FE95Q38556761-EF0D0F7A-2B0D-4BAE-8796-5B4295973850Q38820422-5BA805C0-394C-4706-847E-5A96D4B008EFQ39386505-B6705DDE-A4B6-4266-AEC2-CD2A12ED0F0BQ47333126-CDD05666-3DC0-4294-8A0E-3501757F60D5Q55383414-9F2D5A4C-28EC-4DDF-9D79-576719BBB573
P2860
Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and disposition.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Impact of surface derivatizati ...... rmacokinetics and disposition.
@en
Impact of surface derivatizati ...... rmacokinetics and disposition.
@nl
type
label
Impact of surface derivatizati ...... rmacokinetics and disposition.
@en
Impact of surface derivatizati ...... rmacokinetics and disposition.
@nl
prefLabel
Impact of surface derivatizati ...... rmacokinetics and disposition.
@en
Impact of surface derivatizati ...... rmacokinetics and disposition.
@nl
P2093
P50
P356
P1476
Impact of surface derivatizati ...... armacokinetics and disposition
@en
P2093
Guy Y Krippner
Michael P Giannis
Peter Karellas
Scott A Henderson
P304
P356
10.1021/MP070047S
P407
P577
2007-10-23T00:00:00Z